Biomind Labs Inc.
BMNDF
$0.0158
-$0.0842-84.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 94.28% | 85.07% | 78.16% | 51.50% | 64.65% |
| Total Depreciation and Amortization | 0.00% | -30.16% | -42.11% | -71.79% | -79.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -207.38% | -220.55% | -182.46% | 96.37% | 39.63% |
| Change in Net Operating Assets | 841.42% | 111.21% | -79.38% | -109.82% | -104.21% |
| Cash from Operations | 60.25% | 61.88% | 53.73% | 48.07% | 63.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -71.90% | -62.57% | -60.12% | -50.60% | 14.92% |
| Total Debt Repaid | -- | -- | -- | 105.68% | 103.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -72.97% | -63.43% | -60.35% | -49.88% | 23.17% |
| Foreign Exchange rate Adjustments | 158.00% | -23.79% | 1,773.33% | 154.39% | -37.26% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -- |
| Net Change in Cash | -19.57% | -242.77% | -1,238.89% | 56.97% | 97.16% |